Foundation for Innovative New Diagnostics-医療機器分野:企業M&A・提携分析

◆英語タイトル:Foundation for Innovative New Diagnostics - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8012884
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月27日
◆ページ数:24
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スイス
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Foundation for Innovative New Diagnostics (FIND) is a non-profit organization that offers diagnostic tests. The organization develops and implements new diagnostic technologies for the development of diagnostic tests. Its services include diagnostic technologies development, quality-assured project management framework, product development services, buruli ulcer diagnosis, chagas disease diagnostic solutions, hat diagnostic solutions, and tuberclosis diagnostic solutions. FIND also provides malaria therapy programs, neglected tropical diseases therapy programs, tuberculosis therapy programs, HIV therapy programs, and cross-cutting themes solutions. The organization has its presence in Switzerland, India, Uganda, and South Africa. FIND is headquartered in Geneva, Switzerland.

Foundation for Innovative New Diagnostics – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Foundation for Innovative New Diagnostics, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Foundation for Innovative New Diagnostics, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Foundation for Innovative New Diagnostics, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Foundation for Innovative New Diagnostics, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Foundation for Innovative New Diagnostics, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Foundation for Innovative New Diagnostics, Medical Equipment, Deal Details 11
Partnerships 11
Chembio Diagnostics Enters into Agreement with FIND 11
Fujifilm Enters into Co-Development Contract with Foundation for Innovative New Diagnostics 12
Cepheid Enters into Agreement with Foundation for Innovative New Diagnostics 13
Foundation for Innovative New Diagnostics Enters into Agreement with Molbio Diagnostics 14
Foundation for Innovative New Diagnostics Enters into Agreement with QuantuMDx 15
Foundation for Innovative New Diagnostics Enters into Agreement with Cepheid and Rutgers 16
Lumora And FIND Enter Into Agreement To Develop Molecular Diagnostic Test For Malaria 17
Global BioDiagnostics Extends Co-Development Agreement With Foundation for Innovative New Diagnostics 18
FIND Enters Into An Agreement With Global BioDiagnostics 19
Cepheid Enters Into Co-Development Agreement With FIND 20
Foundation for Innovative New Diagnostics – Key Competitors 21
Foundation for Innovative New Diagnostics – Key Employees 22
Foundation for Innovative New Diagnostics – Locations And Subsidiaries 23
Head Office 23
Other Locations & Subsidiaries 23
Appendix 24
Methodology 24
About GlobalData 24
Contact Us 24
Disclaimer 24

List of Tables
Foundation for Innovative New Diagnostics, Medical Equipment, Key Facts 2
Foundation for Innovative New Diagnostics, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Foundation for Innovative New Diagnostics, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Foundation for Innovative New Diagnostics, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Foundation for Innovative New Diagnostics, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Foundation for Innovative New Diagnostics, Deals By Market, 2011 to YTD 2017 8
Foundation for Innovative New Diagnostics, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Chembio Diagnostics Enters into Agreement with FIND 11
Fujifilm Enters into Co-Development Contract with Foundation for Innovative New Diagnostics 12
Cepheid Enters into Agreement with Foundation for Innovative New Diagnostics 13
Foundation for Innovative New Diagnostics Enters into Agreement with Molbio Diagnostics 14
Foundation for Innovative New Diagnostics Enters into Agreement with QuantuMDx 15
Foundation for Innovative New Diagnostics Enters into Agreement with Cepheid and Rutgers 16
Lumora And FIND Enter Into Agreement To Develop Molecular Diagnostic Test For Malaria 17
Global BioDiagnostics Extends Co-Development Agreement With Foundation for Innovative New Diagnostics 18
FIND Enters Into An Agreement With Global BioDiagnostics 19
Cepheid Enters Into Co-Development Agreement With FIND 20
Foundation for Innovative New Diagnostics, Key Competitors 21
Foundation for Innovative New Diagnostics, Key Employees 22
Foundation for Innovative New Diagnostics, Other Locations 23

★海外企業調査レポート[Foundation for Innovative New Diagnostics-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Post Holdings, Inc.:戦略・SWOT・企業財務分析
    Post Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary Post Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • The Portage la Prairie Mutual Insurance Company:企業の戦略的SWOT分析
    The Portage la Prairie Mutual Insurance Company - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competito …
  • Sumitomo Rubber Industries Ltd (5110):企業の財務・戦略的SWOT分析
    Sumitomo Rubber Industries Ltd (5110) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Ascoma Group:企業の戦略・SWOT・財務情報
    Ascoma Group - Strategy, SWOT and Corporate Finance Report Summary Ascoma Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • PSR Group BV:製薬・医療:M&Aディール及び事業提携情報
    Summary PSR Group BV (PSR) is a contract research and staffing consultancy service provider. The company operates through two divisions such as PSR Orphan Experts and PSR Pharma Resource. Its PSR Orphan Experts is a contract research organization that concentrates on orphan drug development. The com …
  • Sunflower Electric Power Corporation:企業の戦略的SWOT分析
    Sunflower Electric Power Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and majo …
  • Student Transportation Inc.:企業の戦略・SWOT・財務情報
    Student Transportation Inc. - Strategy, SWOT and Corporate Finance Report Summary Student Transportation Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Merck & Co Inc (MRK):医療機器:M&Aディール及び事業提携情報
    Summary Merck & Co Inc (Merck) is a biopharmaceutical company that focuses on the discovery, development, manufacture and commercialization of prescription medicines, biologic therapies, vaccines and animal health products. It offers prescription products for treating cardiovascular, cancer, immune …
  • Zain Group (ZAIN):企業の財務・戦略的SWOT分析
    Zain Group (ZAIN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Japan Petroleum Exploration Co Ltd (1662):企業の財務・戦略的SWOT分析
    Japan Petroleum Exploration Co Ltd (1662) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • Myers Industries Inc (MYE):企業の財務・戦略的SWOT分析
    Summary Myers Industries Inc (Myers) is a chemical company that manufactures and distributes plastic and rubber products. The company offers plastic storage containers, rubber tire repair products, custom plastic and rubber products, tire balancers and tire retread products. It also provides materia …
  • National Presto Industries Inc (NPK):企業の財務・戦略的SWOT分析
    Summary National Presto Industries Inc (National Presto) operates as a consumer product manufacturer that provides pressure cookers and electric appliances. The company provides products such as clocks and timers, coffee makers, bacon cookers, canners, curly cutters, deep fryers, griddles, grills, d …
  • Micronics Inc:企業の製品パイプライン分析2018
    Summary Micronics Inc (Micronics) is a medical device company that develops and markets in vitro diagnostic products. The company provides products that include aborhcard and pannat system. Its research and development products comprise single-use, stand alone, disposable microfluidics-enabled cartr …
  • Benvenue Medical, Inc.:医療機器:M&Aディール及び事業提携情報
    Summary Benvenue Medical, Inc (Benvenue Medical) is a manufacturer, designer and distributor of minimally invasive systems and other medical devices. The product portfolio of the company includes Luna, a 3D interbody fusion system designed for the treatment to restore disc height. Blazer, is a verte …
  • APEIRON Biologics AG:製薬・医療:M&Aディール及び事業提携情報
    Summary APEIRON Biologics AG (APEIRON) is a clinical-stage biotechnology company that concentrates on the development of biological and immunological solutions for the treatment of various cancers. The company’s pipeline products include APN01, APN301, APN311, APN401, APN411, APN421 and APN431. Its …
  • Troy Resources Limited:企業の戦略・SWOT・財務情報
    Troy Resources Limited - Strategy, SWOT and Corporate Finance Report Summary Troy Resources Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Saudi Arabian Oil Co (2222):企業の財務・戦略的SWOT分析
    Saudi Arabian Oil Co (2222) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Affimed GmbH (AFMD):企業の財務・戦略的SWOT分析
    Summary Affimed GmbH (Affimed), formerly Affimed Therapeutics AG, a subsidiary of Affimed NV, discovers and develops immunotherapies to treat hematologic cancers and solid tumors. The company is investigating AFM13, an innate cell engager, for the treatment of Peripheral T cell lymphoma, transformed …
  • Islami Bank Bangladesh Ltd:企業の戦略・SWOT・財務分析
    Islami Bank Bangladesh Ltd - Strategy, SWOT and Corporate Finance Report Summary Islami Bank Bangladesh Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Neurotez Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Neurotez Inc (Neurotez) is a biotechnology company that develops and markets leptin product, a novel hormone replacement therapy for Alzheimer’s disease (AD). The company's product pipeline includes leptin, NT1, NT2, and others. Its product leptin is an adipocyte hormone that controls energy …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆